Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting
  • Home
  • Signaling Pathways

Signaling Pathways

Items 41-50 of 62

Page
per page
  1. GSK2269557
    C5012 GSK2269557
    Summary: inhibitor of PI3Kδ
      ≤0.2 mg/mL
  2. GDC-0032
    B1047 GDC-0032
    Target: PI3K
    Summary: PI3Kα inhibitor
      ≥23.05 mg/mL
  3. GSK2636771
    B2186 GSK2636771
    Target: PI3K
    Summary: PIK3 inhibitor
      insoluble in H2O; insoluble in EtOH; ≥10.83 mg/mL
  4. BAY 80-6946 (Copanlisib)
    B2178 BAY 80-6946 (Copanlisib)
     1 Citation
    Target: PI3K
    Summary: PI3K inhibitor
      insoluble in DMSO; insoluble in H2O; insoluble in EtOH
  5. CH5132799
    B2183 CH5132799
    Summary: Class I PI3K inhibitor
      Soluble in DMSO
  6. AS-252424
    B2180 AS-252424
    Target: Akt|PI3K
    Summary: PI3Kγ inhibitor,novel and potent
      insoluble in EtOH; insoluble in H2O; ≥30.5 mg/mL
  7. AS-604850
    B2181 AS-604850
    Summary: PI3Kγ inhibitor,selective and ATP-competitve
      Soluble in DMSO
  8. PIK-293
    B2187 PIK-293
    Summary: PI3K inhibitor
      Soluble in DMSO
  9. PIK-294
    B2188 PIK-294
    Summary: highly selective p110δ inhibitor
      ≥24.5 mg/mL
  10. TG100713
    B2177 TG100713
    Target: PI3K
    Summary: pan-PI3K inhibitor
      soluble in DMSO

Items 41-50 of 62

Page
per page